Achaogen(AKAO)- NASDAQ
From other sites
Company Description
Achaogen, Inc. operates as a clinical-stage biopharmaceutical company. It discovers, develops and commercializes novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections. develops plazomicin for the treatment of serious bacterial infections due to MDR enterobacteriaceae,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States